Document is current

Any future updates will be listed below

Teprotumumab nel trattamento dell’orbitopatia basedowiana di lunga durata e scarsamente attiva

Crossref DOI link: https://doi.org/10.1007/s40619-025-01665-2

Published Online: 2025-07-15

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark